The Right TraderBeta

Ultragenyx Pharmaceutical Inc.

RARE
—
Advanced chart & tools →
Ultragenyx Pharmaceutical Inc.RARE
$0.00
+$0.00(+NaN%)Past Year
$0.00$0.00$0.00$0.00
Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap
—
P/E ratio
—
EPS (diluted)
$-5.83
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$673.00M
Net income
$-575.00M
Net margin
-85.4%
Gross margin
—

Dividends & financials

Ultragenyx Pharmaceutical Inc. (RARE) reported revenue of $673.00M and net income of $-575.00M, or $-5.83 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.